tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Young Li, 5 are a BUY (41.67%), 7 are a HOLD (58.33%).
Analyst Young Li, currently employed at JEFFERIES, carries an average stock price target met ratio of 30% that have a potential upside of 10.33% achieved within 30 days. Previously, Young Li worked at UBS.
Young Li’s has documented 24 price targets and ratings displayed on 5 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on RXST, Rxsight at 10-Jul-2025.
Analyst best performing recommendations are on CNMD (CONMED).
The best stock recommendation documented was for CNMD (CONMED) at 10/11/2022. The price target of $85 was fulfilled within 31 days with a profit of $10.04 (13.39%) receiving and performance score of 4.32.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 03-Nov-2023
$17
$1.9 (12.58%)
$16
4 months 29 days ago
(27-Feb-2026)
14/22 (63.64%)
$2.64 (18.38%)
129
Buy Since 31-Jul-2025
$16
$0.9 (5.96%)
11 months 25 days ago
(31-Jul-2025)
1/1 (100%)
$7.74 (93.70%)
260
Hold Since 14-Oct-2022
$24
$8.9 (58.94%)
$23
2 years 1 months 27 days ago
(29-May-2024)
5/5 (100%)
$-1.64 (-6.40%)
129
Buy Since 22-Feb-2019
$32
$17.24 (116.80%)
$41
2 years 11 months 17 days ago
(09-Aug-2023)
1/2 (50%)
$11.99 (59.92%)
73
Buy Since 15-Nov-2021
$35
$20.24 (137.13%)
$55
4 years 4 months 17 days ago
(09-Mar-2022)
0/2 (0%)
$8.78 (33.49%)
What Year was the first public recommendation made by Young Li?
